Table 4. Multivariate analyses.
| A | ||||
| Parameter | HR | 95% confidence interval | p-Value | |
| min | max | |||
| pT category | 1.397 | 0.98 | 1.99 | 0.064 |
| Lymph node metastasis | 1.942 | 1.199 | 3.147 | 0.007 |
| Grading | 1.046 | 0.634 | 1.724 | 0.86 |
| Age | 4.093 | 2.418 | 6.929 | 0.001 |
| LC3B dot-like staining | 0.599 | 0.376 | 0.954 | 0.031 |
| B | ||||
| Parameter | HR | 95% confidence interval | p-Value | |
| min | max | |||
| pT category | 1.355 | 0.95 | 1.933 | 0.094 |
| Lymph node metastasis | 2.088 | 1.284 | 3.396 | 0.003 |
| Grading | 1.071 | 0.645 | 1.777 | 0.792 |
| Age | 4.084 | 2.409 | 6.921 | 0.001 |
| p62 dot-like/cytoplasmic | 0.507 | 0.285 | 0.902 | 0.021 |
| C | ||||
| Parameter | HR | 95% confidence interval | p-Value | |
| min | max | |||
| pT category | 1.408 | 0.983 | 2.016 | 0.062 |
| Lymph node metastasis | 1.87 | 1.151 | 3.037 | 0.011 |
| Grading | 1.058 | 0.641 | 1.749 | 0.825 |
| Age | 4.024 | 2.374 | 6.82 | 0.001 |
| LC3B dot-like/p62 dot-like-cytoplasmic | 0.751 | 0.607 | 0.928 | 0.008 |
A) model including LC3B dot-like immunohistochemical staining; B) model including p62 dot-like-cytoplasmic immunohistochemical staining; C) model including the combination of LC3B dot-like/p62 dot-like-cytoplasmic immunohistochemical staining.